Hill-Rom Holdings Inc. (HRC) Rating Lowered to Hold at Zacks Investment Research
Hill-Rom Holdings Inc. (NYSE:HRC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday.
According to Zacks, “Hill-Rom ended fiscal 2017 on a promising note with its fourth quarter numbers squarely beating the Zacks Consensus Estimate. The company’s outcome on a year-over-year basis was also impressive. The company’s year-over-year outcome was impressive along with record level of gross margin. We are upbeat about the company to remain on a solid growth trajectory over the near term based on its strong 2017 guidance. Based on several positive catalysts, we expect the company to expand geographically in the coming quarters. Notably, in the last reported quarter, Hill-Rom posted strong growth in both Asia-Pacific and the U.S. However, Hill-Rom’s persistent poor performance in the International front, especially in the Middle East and Latin America keeps us concerned. Unfortunately no near term improvement can be expected in the existing capital crunch condition that eventually led to economic and political downturns in these economies.”
Shares of Hill-Rom Holdings (NYSE:HRC) opened at 54.66 on Wednesday. Hill-Rom Holdings has a 52 week low of $42.99 and a 52 week high of $63.12. The stock has a market cap of $3.65 billion, a price-to-earnings ratio of 29.39 and a beta of 1.20. The stock’s 50 day moving average is $59.05 and its 200 day moving average is $54.47.
Hill-Rom Holdings (NYSE:HRC) last posted its quarterly earnings data on Thursday, November 3rd. The medical technology company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.13 by $0.05. Hill-Rom Holdings had a net margin of 4.67% and a return on equity of 18.93%. The business had revenue of $706 million for the quarter, compared to analyst estimates of $701.39 million. During the same quarter in the previous year, the firm posted $0.89 earnings per share. Hill-Rom Holdings’s quarterly revenue was up 23.0% on a year-over-year basis. On average, equities analysts forecast that Hill-Rom Holdings will post $3.80 EPS for the current year.
Hedge funds and other institutional investors have recently modified their holdings of the company. Copper Rock Capital Partners LLC increased its position in shares of Hill-Rom Holdings by 1.6% in the second quarter. Copper Rock Capital Partners LLC now owns 589,208 shares of the medical technology company’s stock valued at $29,726,000 after buying an additional 9,148 shares in the last quarter. Nordea Investment Management AB increased its position in shares of Hill-Rom Holdings by 278.3% in the second quarter. Nordea Investment Management AB now owns 12,670 shares of the medical technology company’s stock valued at $639,000 after buying an additional 9,321 shares in the last quarter. Foundry Partners LLC purchased a new position in shares of Hill-Rom Holdings during the second quarter valued at about $9,209,000. Capstone Asset Management Co. increased its position in shares of Hill-Rom Holdings by 4.2% in the second quarter. Capstone Asset Management Co. now owns 7,225 shares of the medical technology company’s stock valued at $365,000 after buying an additional 290 shares in the last quarter. Finally, Fisher Asset Management LLC increased its position in shares of Hill-Rom Holdings by 0.4% in the second quarter. Fisher Asset Management LLC now owns 1,576,535 shares of the medical technology company’s stock valued at $80,466,000 after buying an additional 5,975 shares in the last quarter. Hedge funds and other institutional investors own 83.10% of the company’s stock.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.
Receive News & Stock Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related stocks with our FREE daily email newsletter.